191 related articles for article (PubMed ID: 31319607)
21. Melatonin receptor agonist ramelteon activates the extracellular signal-regulated kinase 1/2 in mouse cerebellar granule cells.
Imbesi M; Uz T; Manev H
Neuroscience; 2008 Sep; 155(4):1160-4. PubMed ID: 18664376
[TBL] [Abstract][Full Text] [Related]
22. The role of melatonin membrane receptors in melatonin-dependent oxytocin secretion from the rat hypothalamo-neurohypophysial system - an in vitro and in vivo approach.
Juszczak M; Wolak M; Bojanowska E; Piera L; Roszczyk M
Endokrynol Pol; 2016; 67(5):507-514. PubMed ID: 26884304
[TBL] [Abstract][Full Text] [Related]
23. Melatonin administration alters nicotine preference consumption via signaling through high-affinity melatonin receptors.
Horton WJ; Gissel HJ; Saboy JE; Wright KP; Stitzel JA
Psychopharmacology (Berl); 2015 Jul; 232(14):2519-30. PubMed ID: 25704105
[TBL] [Abstract][Full Text] [Related]
24. The influence od melatonin receptors antagonists, luzindole and 4-phenyl-2-propionamidotetralin (4-P-PDOT), on melatonin-dependent vasopressin and adrenocorticotropic hormone (ACTH) release from the rat hypothalamo-hypophysial system. In vitro and in vivo studies.
Juszczak M; Roszczyk M; Kowalczyk E; Stempniak B
J Physiol Pharmacol; 2014 Dec; 65(6):777-84. PubMed ID: 25554981
[TBL] [Abstract][Full Text] [Related]
25. The antidepressant-like effect of the melatonin receptor ligand luzindole in mice during forced swimming requires expression of MT2 but not MT1 melatonin receptors.
Sumaya IC; Masana MI; Dubocovich ML
J Pineal Res; 2005 Sep; 39(2):170-7. PubMed ID: 16098095
[TBL] [Abstract][Full Text] [Related]
26. A new melatonin receptor ligand with mt1-agonist and MT2-antagonist properties.
Nonno R; Lucini V; Spadoni G; Pannacci M; Croce A; Esposti D; Balsamini C; Tarzia G; Fraschini F; Stankov BM
J Pineal Res; 2000 Nov; 29(4):234-40. PubMed ID: 11068946
[TBL] [Abstract][Full Text] [Related]
27. The inhibitory effect of melatonin on mammary function of lactating dairy goats†.
Zhang W; Chen J; Zhao Y; Zheng Z; Song Y; Wang H; Tong D
Biol Reprod; 2019 Feb; 100(2):455-467. PubMed ID: 30346485
[TBL] [Abstract][Full Text] [Related]
28. Alterations of melatonin receptors MT1 and MT2 in the hypothalamic suprachiasmatic nucleus during depression.
Wu YH; Ursinus J; Zhou JN; Scheer FA; Ai-Min B; Jockers R; van Heerikhuize J; Swaab DF
J Affect Disord; 2013 Jun; 148(2-3):357-67. PubMed ID: 23357659
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of SOX18 expression in non-small cell lung cancer.
Jethon A; Pula B; Olbromski M; Werynska B; Muszczynska-Bernhard B; Witkiewicz W; Dziegiel P; Podhorska-Okolow M
Int J Oncol; 2015 Jan; 46(1):123-32. PubMed ID: 25310193
[TBL] [Abstract][Full Text] [Related]
30. [Sites and mechanisms of action of melatonin in mammals: the MT1 and MT2 receptors].
Schuster C
J Soc Biol; 2007; 201(1):85-96. PubMed ID: 17762828
[TBL] [Abstract][Full Text] [Related]
31. Molecular determinants for the differential coupling of Galpha(16) to the melatonin MT1, MT2 and Xenopus Mel1c receptors.
Lai FP; Mody SM; Yung LY; Kam JY; Pang CS; Pang SF; Wong YH
J Neurochem; 2002 Mar; 80(5):736-45. PubMed ID: 11948236
[TBL] [Abstract][Full Text] [Related]
32. 17Beta-estradiol modulates hMT1 melatonin receptor function.
Masana MI; Soares JM; Dubocovich ML
Neuroendocrinology; 2005; 81(2):87-95. PubMed ID: 15809517
[TBL] [Abstract][Full Text] [Related]
33. Evidence that membrane-bound G protein-coupled melatonin receptors MT1 and MT2 are not involved in the neuroprotective effects of melatonin in focal cerebral ischemia.
Kilic U; Yilmaz B; Ugur M; Yüksel A; Reiter RJ; Hermann DM; Kilic E
J Pineal Res; 2012 Mar; 52(2):228-35. PubMed ID: 21913972
[TBL] [Abstract][Full Text] [Related]
34. Regional upregulation of hippocampal melatonin MT2 receptors by valproic acid: therapeutic implications for Alzheimer's disease.
Bahna SG; Sathiyapalan A; Foster JA; Niles LP
Neurosci Lett; 2014 Jul; 576():84-7. PubMed ID: 24909617
[TBL] [Abstract][Full Text] [Related]
35. [Evaluation of the role of melatonin in the metastasis of papillary thyroid carcinoma].
Fan L; Xiong YP; Liu HT; Min X; Tang YQ; Zhang ZY
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Nov; 33(11):1060-1064. PubMed ID: 31914295
[No Abstract] [Full Text] [Related]
36. Melatonin receptors subtypes (MT1 and MT2) in the uterus masculinus of mature male european bison. Biological and seasonal reproductive role.
Tabecka-Lonczynska A; Mytych J; Solek P; Kulpa-Greszta M; Koziorowski M
J Physiol Pharmacol; 2018 Feb; 69(1):67-73. PubMed ID: 29769422
[TBL] [Abstract][Full Text] [Related]
37. Neural stem cells express melatonin receptors and neurotrophic factors: colocalization of the MT1 receptor with neuronal and glial markers.
Niles LP; Armstrong KJ; Rincón Castro LM; Dao CV; Sharma R; McMillan CR; Doering LC; Kirkham DL
BMC Neurosci; 2004 Oct; 5():41. PubMed ID: 15511288
[TBL] [Abstract][Full Text] [Related]
38. Activation of melatonin receptor 2 but not melatonin receptor 1 mediates melatonin-conferred cardioprotection against myocardial ischemia/reperfusion injury.
Han D; Wang Y; Chen J; Zhang J; Yu P; Zhang R; Li S; Tao B; Wang Y; Qiu Y; Xu M; Gao E; Cao F
J Pineal Res; 2019 Aug; 67(1):e12571. PubMed ID: 30903623
[TBL] [Abstract][Full Text] [Related]
39. MT1 and MT2 melatonin receptors: ligands, models, oligomers, and therapeutic potential.
Zlotos DP; Jockers R; Cecon E; Rivara S; Witt-Enderby PA
J Med Chem; 2014 Apr; 57(8):3161-85. PubMed ID: 24228714
[TBL] [Abstract][Full Text] [Related]
40. Sleep-wake characterization of double MT₁/MT₂ receptor knockout mice and comparison with MT₁ and MT₂ receptor knockout mice.
Comai S; Ochoa-Sanchez R; Gobbi G
Behav Brain Res; 2013 Apr; 243():231-8. PubMed ID: 23333399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
